Linical Co., Ltd.
Notice Regarding Dividend Receipt from Consolidated Subsidiary
Received dividend from consolidated subsidiary LINICAL KOREA CO., LTD. Amount is 1,000 million Korean won (110 million yen), receipt date on August 5, 2026. It will be recorded as ordinary income in the individual financial statements for the fiscal year ending March 2027 and has no impact on consolidated results.
Key Figures
- Dividend amount: 1,000 million Korean won (110 million yen)
- Dividend receipt date: August 5, 2026
- Target consolidated subsidiary: LINICAL KOREA CO., LTD.
AI要約
Key points of the news
We received a dividend from the consolidated subsidiary LINICAL KOREA CO., LTD., amounting to 1,000 million Korean won (110 million yen). Receipt date is August 5, 2026. In the fiscal year ending March 2027, it will be recorded as ordinary income in the separate financial statements, with no impact on the consolidated results.
Impact and considerations going forward
Since the dividend is from a consolidated subsidiary, it does not affect the group's consolidated results. However, it may affect the individual financial statements. Although exchange rate information is provided, since the dividend is in Korean won, exchange effects should be considered separately.
Lynical, Inc.
Company overview · Stock price · Financial data · All IR
